These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H. J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605 [Abstract] [Full Text] [Related]
14. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases]. Yasumoto T, Murakami T, Katsumoto Y, Hashimoto T, Noda S, Murata K, Kinuta M, Nakamura H. Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881 [Abstract] [Full Text] [Related]
15. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491 [Abstract] [Full Text] [Related]